Conference on Biosimilars 2019

Conference on Biosimilars 2019

The growing role of biologics and biosimilars in Greece 

Patient access to safe and cost-effective treatments is an important goal for the health care system. As the availability and use of biosimilars, including those determined to be interchangeable, increases, their potential to lower costs and improve patient access to treatment grows. However, the extent of such growth is, in part, dependent on various stakeholders’ decisions to provide, pay for, or use these products in a safe and thoughtful manner. Ongoing stakeholder collaboration, educational activities, and review of current government or payer policies are required to optimize the uptake of biological products, including biosimilars.


Participation fees with Early Bird Until 27 August  

Individual participation250€ + 24% VAT
4 Company registrations (3+1 free): 750€ + 24% VAT
8 Company registrations (6+2 free)1500€ + 24% VAT


Participation fees after 27 August  

Individual participation300€ + 24% VAT
4 Company registrations (3+1 free): 900€ + 24% VAT
8 Company registrations (6+2 free)1800€ + 24% VAT


Early Bird Conference Ticket € 250,00 Έληξε η διάθεση
Full Price Conference Ticket € 300,00
Free Conference Ticket

Public Servants, Nurses, Pharmacists & pharmacy professionals, Researchers, Patient Advocates

DOCTOR Conference Ticket (Free)
STUDENT Conference Ticket (Free)

Ο ΦΠΑ δεν περιλαμβάνεται


Τρίτη, 24 Σεπτεμβρίου 2019 9:00 πμ


Divani Caravel Hotel, Macedonia Hall
Λεωφόρος Βασιλέως Αλεξάνδρου 2
161 21 Αθήνα
Κεντρικός Τομέας Αθηνών, Ελλάδα

Προβολή μεγαλύτερου χάρτη